It’s prostate cancer awareness month. See how The Urology Group has been treating men with CyberKnife for the past 10 years! Plus meet our 4 newest physicians!
Steve Abbott, a 10-year advanced prostate cancer survivor, is finally getting a life-extending treatment called Pluvicto, which has been in short supply in the U.S. Dr. Brooke Edwards and Dr. Gary Kirsh talk about the therapy itself, as well as frustrations when these specialized drugs are in short supply.
The Urology Group seeks to help patients with advanced prostate cancer find drugs like Pluvicto that are in short supply. One patient received his medication from Italy due to limited quantities in the U.S. Being your own advocate is essential to making sure you can take advantage of every treatment option available.
View All News Releases
Dr. Gary Kirsh talks about the rise in vasectomy procedures since the Supreme Court’s decision to overturn Roe v. Wade.
The Urology Group now offers Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) or enlarged prostate.
For the second year, Ohio Business Magazine has selected The Urology Group as one of the Best Workplaces in Ohio.
View All Press Releases
We welcome the media to contact us for interviews with our physicians and leadership team on a variety of healthcare topics. Learn more about The Urology Group by clicking on this At-A-Glance sheet or by reading our 2016 Anniversary Report.
|Robin Brinck||Carol Bross-McMahon|
|(513) 841-7488||(513) 673-2720|